MRI study of cavum septi pellucidi in schizophrenia, affective disorder, and schizotypal personality disorder

American Journal of Psychiatry

Volumn 155, Issue 4, 1998, Pages 509-515

  Kwon, Jun Soo ^b   Shenton, Martha E ^a   Hirayasu, Yoshio ^b   Salisbury, Dean F ^b   Fischer, Iris A ^b   Dickey, Chandlee C ^b   Yurgelun Todd, Deborah ^b   Tohen, Mauricio ^b   Kikinis, Ron ^b   Jolesz, Ferenc A ^b   McCarley, Robert W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MENTAL DISEASE; NEUROPATHOLOGY; NEURORADIOLOGY; NEUROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SEPTUM PELLUCIDUM;

EID: 20244372095     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.155.4.509     Document Type: Article

References (52)

1. Sarwar M: The septum pellucidum: normal and abnormal. Am J Neuroradiol 1989; 10:989-1005
2. Shaw CM, Alvord EC: Cavum septi pellucidi er vergae: their normal and pathological state. Brain 1969; 92:213-224
3. Rakic P, Yakovlev PI: Development of corpus callosum and cavum septi in man. J Comp Neurol 1968; 132:355-362
4. Hoff AL, Neal C, Kushner M, DeLisi LE: Gender differences in corpus callosum size in first-episode schizophrenia. Biol Psychiatry 1994; 35:913-919
5. Shenton ME, Kikinis R, Jolesz FA, Pollak SD, LeMay M, Wible CG, Hokama H, Martin J, Metcalf D, Coleman M, McCarley RW: Abnormalities of the left temporal lobe and thought disorder in schizophrenia: a quantitative magnetic resonance imaging study. N Engl J Med 1992; 327:604-612
6. Bogerts B, Ashtari M, Degreef G, Alvir JM, Bilder RM, Lieberman JA: Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res 1990; 35:1-13
7. Barta PE, Pearlson GD, Powers RE, Richards SS, Tune LE: Auditory hallucinations and smaller superior temporal gyrus volume in schizophrenia. Am J Psychiatry 1990; 147:1457-1462
8. Rossi A, Stratta P, Mancini F, Gallucci M, Mattei P, Core L, Di Michele V, Casacchia M: Magnetic resonance imaging findings of amygdala-anterior hippocampus shrinkage in male patients with schizophrenia. Psychiatry Res 1994; 52:43-53
9. Raine A, Harrison GN, Reynolds GP, Sheard C, Cooper JE, Medley I: Structural and functional characteristics of the corpus callosum in schizophrenics, psychiatric controls, and normal controls. Arch Gen Psychiatry 1990; 47:1060-1064
10. Rossi A, Stratta P, Gallucci M, Passariello R, Casacchia M: Quantification of corpus callosum and ventricles in schizophrenia with nuclear magnetic resonance imaging: a pilot study. Am Psychiatry 1989; 146:99-101
11. Andreasen NC, Nasrallah HA, Dunn V, Olson SO, Grove WM, Ehrhardt JC, Coffman JA, Crossett JH: Structural abnormalities in the frontal system in schizophrenia: a magnetic resonance imaging study. Arch Gen Psychiatry 1986; 43:136-144
12. DeLisi LE, Lieberman J: Longitudinal perspective on the pathophysiology of schizophrenia: examining the neurodevelopmental versus neurodegenerative hypotheses. Schizophr Res 1991; 5: 183-210
13. Murray RM, O'Callaghan E, Castle J, Lewis SW: A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull 1992; 18:319-332
14. Bonitz G: Zur klinisch-diagnostischen Bedeutung des erweiterten und kommunizierenden Cavum sepri pellucidi. Nervenarzt 1969; 40:121-128
15. Sonntag I, Nadjimi M, Lajosi F, Fuchs G: Anlagebedingte Gehirnanomalien der Mittellinie. Nervenarzt 1971; 42:531-539
16. Lewis SW, Mezey GC: Clinical correlates of septum pellucidum cavities: an unusual association with psychosis. Psychol Med 1985; 15:43-54
17. Nakano S, Hojo H, Kataoka K, Ramasak S: Age related incidence of cavum septi pellucidi and cavum vergae on CT scans of pediatric patients. J Comput Assist Tomogr 1981; 5:348-349
18. Corsellis JN, Bruton CJ, Freeman-Browne D: The aftermath of boxing. Psychol Med 1973; 3:270-303
19. Degreef G, Lantos G, Bogerts B, Ashtari M, Lieberman J: Abnormalities of the septum pellucidum on MR scans in first-episode schizophrenic patients. Am J Neuroradiol 1992; 13:835-840
20. Scott TF, Price TP, George MS, Brillman J, Rothfus W: Midline cerebral malformations and schizophrenia. J Neuropsychiatry Clin Neurosci 1993; 5:287-293
21. Jurjus GJ, Nasrallah HA, Olson SC, Schwarzkopf SB: Cavum septum pellucidum in schizophrenia, affective disorder and healthy controls: a magnetic resonance imaging study. Psychol Med 1993; 23:319-322
22. DeLisi LE, Hoff AL, Kushner M, Degreef G: Increased prevalence of cavum septum pellucidum in schizophrenia. Psychiatry Res Neuroimaging 1993; 50:193-199
23. Nopoulos P, Swayze V, Flaum M, Ehrhardt JC, Yuh WT, Andreasen NC: Cavum septi pellucidi in normals and patients with schizophrenia as detected by magnetic resonance imaging. Biol Psychiatry 1997; 41:1102-1108
24. Schwidde JT: Incidence of cavum septi pellucidi and cavum vergae in 1,032 human brains. Arch Neurol Psychiatry 1952; 67:625-633
25. Degreef G, Bogerts B, Falkai P, Greve B, Lantos G, Ashtari M, Lieberman J: Increased prevalence of the cavum septum pellucidum in magnetic resonance scans and post-mortem brains of schizophrenic patients. Psychiatry Res Neuroimaging 1992; 45:1-13
26. Nasrallah HA: Neurodevelopmental aspects of bipolar affective disorder. Biol Psychiatry 1991; 9:1-2
27. Swayze VW II, Andreasen NC, Alliger RJ, Yuh WT, Ehrhardt JC: Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study. Biol Psychiatry 1992; 31:221-240
28. Shioiri T, Oshitani Y, Kato T, Murashita J, Hamakawa H, Inubushi T, Nagata T, Takahashi S: Prevalence of cavum septum pellucidum detected by MR1 in patients with bipolar disorder, major depression and schizophrenia. Psychol Med 1996; 26:431-434
29. Kendler KK, McGuire M, Gruenberg AM, O'Hare A, Spellman M, Walsh D: The Roscommon family study, I: methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch Gen Psychiatry 1993; 50:527-540
30. Kendler KK, McGuire M, Gruenberg AM, Spellman M, O'Hare A, Walsh D: The Roscommon family study, II: the risk of nonschizophrenic nonaffective psychoses in relatives. Arch Gen Psychiatry 1993; 50:645-652
31. Kendler KK, Diehl SR: The genetics of schizophrenia: a current, genetic-epidemiologic perspective. Schizophr Bull 1993; 2:261-285
32. Siever LJ: Schizophrenia spectrum personality disorder, in American Psychiatric Press Review of Psychiatry, vol 11. Edited by Tasman A, Riba M. Washington, DC, American Psychiatric Press, 1992, pp 25-42
33. Kremen WS, Seidman LJ, Pepple JR, Lyons MJ, Tsuang MT, Faraone SV: Neuropsychological risk indicators for schizophrenia: a review of family studies. Schizophr Bull 1994; 20:103-119
34. Tohen M, Stol IA, Strakowski S, Faedda G, Maye RP, Goodwin D, Kolbrener M, Madigan A: The McLean first-episode psychosis project: six month recovery and recurrence outcome. Schizophr Bull 1992; 18:273-282
35. Spitzer RL, Endicott J: Schedule for Affective Disorders and Schizophrenia - Lifetime Version, 3rd ed. New York, New York State Psychiatric Institute, Biometrics Research, 1978
36. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R-Patient Version 1.0 (SCID-P). Washington, DC, American Psychiatric Press, 1990
37. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). Washington, DC, American Psychiatric Press, 1990
38. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R - Non-Patient Edition (SCID-NP, Version 1.0). Washington, DC, American Psychiatric Press, 1990
39. Andreasen NC: Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, University of Iowa, 1984
40. Andreasen NC: Scale for the Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa, 1981
41. Johnston MH, Holzman PS: Assessing Schizophrenic Thinking: A Clinical and Research Instrument for Measuring Thought Disorder. San Francisco, Jossey-Bass, 1979
42. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:799-812
43. Endicott J, Spitzer RL, Fleiss JL, Cohen J: The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33:766-771
44. Shunk H: Congenital dilatations of the septi pellucidum. Radiology 1963; 81:610-618
45. Voglmaier MM, Seidman LJ, Salisbury D, McCarley RW: Neuropsychological dysfunction in schizotypal personality disorder: a profile analysis. Biol Psychiatry 1997; 41:530-540
46. Trestman RL, Horvath T, Kalus O, Peterson AE, Coccaro E, Mitropoulou V, Apter S, Davidson M, Siever LJ: Event-related potentials in schizotypal personality disorder. J Neuropsychiatry Clin Neurosci 1996; 8:33-40
47. Flaum M, Arndt S, Andreasen NC: The role of gender in studies of ventricular enlargement in schizophrenia: a predominantly male effect. Am J Psychiatry 1990; 147:1327-1332
48. Marhew RJ, Partain CL, Logan TP, Wilson WH: A study of the septum pellucidum and corpus callosum in schizophrenia with MR imaging. Acta Psychiatr Scand 1985; 72:414-121
49. Shenton ME, Wible CG, McCarley RW: A review of magnetic resonance imaging studies of brain abnormalities in schizophrenia, in Brain Imaging in Clinical Psychiatry. Edited by Krishnan KRR, Doraiswamy PM. New York, Marcel Dekker, 1997, pp 297-380
50. Nopoulos P, Swayze V, Andreasen NC: Pattern of brain morphology in patients with schizophrenia and large cavum septi pellucidi. J Neuropsychiatry Clin Neurosci 1996; 8:147-152
51. Andy OJ, Stephan H: The septum in the human brain. J Comp Neurol 1968; 133:383-410
52. Raisman G: The connections of the septum. Brain 1966; 89:317-348